Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats

European Journal of Pharmacology

Volumn 377, Issue 2-3, 1999, Pages 183-186

  Medvedev, Ivan O ^a   Dravolina, Olga A ^a   Bespalov, Anton Y ^a  

^a Valdman Institute of Pharmacology   (Russian Federation)

Author keywords

Drug discrimination; Morphine withdrawal; Naloxone; Nitric oxide (NO) synthase inhibitor; Rat; Y maze

Indexed keywords

7 NITROINDAZOLE; MORPHINE; NALOXONE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DIARRHEA; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TREMOR; WEIGHT REDUCTION; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BODY WEIGHT; DISCRIMINATION LEARNING; DRUG INTERACTIONS; ENZYME INHIBITORS; INDAZOLES; MALE; MAZE LEARNING; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0032792720     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00435-5     Document Type: Article

References (11)

1. G-nitro-L-arginine methyl ester. Life Sci. 52:1993;PL245-249.
2. Herman B.H., Vocci F., Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Neuropsychopharmacology. 13:1995;269-293.
3. Higgins G.A., Sellers E.M. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol. Biochem. Behav. 48:1994;1-8.
4. Higgins G.A., Nguyen P., Sellers E.M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50:1992;PL167-PL172.
5. Jewett D.C., Butelman E.R., Woods J.H. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Res. 715:1996;25-31.
6. Koek W., Colpaert F.C., Vignon J. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection. J. Pharmacol. Exp. Ther. 264:1993;746-756.
7. Medvedev I.O., Dravolina O.A., Bespalov A.Y. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. J. Pharmacol. Exp. Ther. 286:1998;1260-1268.
8. Moore P.K., Babbedge R.C., Wallace P., Gaffeb Z.A., Hart S.L. 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
9. Popik P., Danysz W. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J. Pharmacol. Exp. Ther. 280:1997;854-865.
10. Vaupel B.D., Kimes A.S., London E.D. Nitric oxide synthase inhibitors: preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315-322.
11. Vaupel D.B., Kimes A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324:1997;11-20.